MMP19 and type 2 diabetes mellitus: In separate analyses, equalising treatment with statins alone significantly changed the risk in both groups not on GLDT, whereas equalising treatment with RASi alone changed the risk significantly only in the group with persistent type 2 diabetes (Fig. 4).